Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A plain language summary of the molecular changes in the tumors of people with BRAF V600E–mutant colorectal cancer in the BEACON study
    Editorial

    Kopetz, S.; Murphy, D. A.; Pu, J.; Ciardiello, F.; Desai, J.; Van Cutsem, E.; Wasan, H. S.; Yoshino, T.; Saffari, H.; Zhang, X.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER study: A plain language summary
    Editorial

    Kopetz, S.; Yoshino, T.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Surrogate end points in oncology: Aligning drug development incentives and patient needs
    Correspondence

    Vogel, M.; Yaeger, R.; Stewart, D. J.; Subbiah, V.; David, F. S.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: A randomized phase 3 trial
    Journal Article

    Kopetz, S.; Yoshino, T.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Correlation between grade of clinical response to neoadjuvant therapy for rectal cancer and oncologic outcomes in the era of watch-and-wait
    Journal Article

    Rosen, R. Y.; Bercz, A. P.; Omer, D. M.; Verheij, F. S.; Williams, H.; Malekzadeh, P.; Kong, D. L.; Quezada-Diaz, F. F.; Wei, I. H.; Widmar, M.; more...
    Diseases of the Colon and Rectum (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, patterns of failure, and salvage therapies of a large modern cohort of patients with anal squamous cell carcinoma treated with definitive-intent intensity-modulated radiation therapy
    Journal Article

    Roth O'Brien, D. A.; Hristidis, V. C.; Chakrani, Z.; McCann, P.; Damato, A.; Williams, V.; Cote, N.; Reyngold, M.; Rosen, R.; Connell, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases
    Journal Article

    Gui, C.; Walch, H. S.; Mueller, K. D.; Boe, L. A.; Ilica, A. T.; Strong, J.; Eichholz, J. E.; Yu, K. K. H.; Wilcox, J. A.; Manca, P.; more...
    Journal of Neurosurgery (2025)

    Fulltext@MSK | Save
  • Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur)
    Meeting Abstract

    Romesser, P. B.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save